“Coronary Artery Disease. We see you.” Quite literally, healthcare company Artrya (ASX: AYA) sees your heart disease through its artificial intelligence solution Salix, which uses AI imaging to detect the intensity of your heart disease and aims to leverage its tech to access a global market alongside another jab at its FDA approval. In June
Read More
Coronary heart disease is the most prevalent type of heart disease and the leading single cause of death in Australia, representing 11% of all deaths in 2018. 42% of coronary heart disease related deaths resulted from a heart attack. Medtech company Artrya (ASX: AYA) is working to improve diagnosis of this often silent disease. Their
Read More